SPHAR Activators
The term SPHAR Activators refers to a specific category of chemical compounds designed to modulate the activity of the SPHAR gene or protein. SPHAR, or Spartin Homolog Associated with Lipid Droplets and Rab7, is a gene that encodes a protein associated with lipid droplets, which are intracellular organelles involved in lipid metabolism and storage. The precise biological functions and regulatory mechanisms of SPHAR are subjects of ongoing research within the fields of cell biology and molecular genetics. Activators within the SPHAR Activators class are typically small molecules or chemical agents strategically engineered to interact with the SPHAR gene or protein, with the aim of enhancing its expression or influencing its functional capabilities. These activators serve as valuable tools for researchers to manipulate SPHAR-related processes and explore its potential functions in the context of lipid metabolism and intracellular lipid droplet dynamics.
The mechanism of action for SPHAR Activators may involve various aspects of gene regulation or protein function. These compounds could influence the binding of transcription factors to the promoter region of the SPHAR gene, potentially increasing its transcriptional activity and leading to elevated SPHAR gene expression levels. Alternatively, they might affect post-translational modifications or interactions of the SPHAR protein, such as phosphorylation or protein-protein interactions, which can modulate its stability, function, or subcellular localization within the cell, particularly in association with lipid droplets and the Rab7 protein. Researchers and scientists employ SPHAR Activators in molecular and cellular biology studies to investigate the role of SPHAR in lipid metabolism, lipid droplet dynamics, and potential implications in cellular processes related to lipid storage and utilization. By selectively modulating the gene's activity or protein function, researchers can gain insights into its functions, regulatory mechanisms, and potential involvement in maintaining cellular lipid homeostasis, contributing to a deeper understanding of the molecular processes involving SPHAR and its significance in cellular biology. Overall, SPHAR Activators provide valuable tools for exploring the functions and regulatory mechanisms of SPHAR in the context of lipid metabolism and lipid droplet dynamics within cells.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Hydroxyurea inhibits ribonucleotide reductase, stalling DNA synthesis. This could hypothetically upregulate SPHAR as part of a cellular attempt to manage S-phase arrest. | ||||||
Aphidicolin | 38966-21-1 | sc-201535 sc-201535A sc-201535B | 1 mg 5 mg 25 mg | $84.00 $306.00 $1104.00 | 30 | |
Aphidicolin is a specific inhibitor of DNA polymerase, which could lead to S-phase arrest and potentially influence SPHAR expression as part of the DNA damage response. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
5-Fluorouracil is incorporated into RNA and DNA, disrupting normal synthesis and function. It might induce SPHAR expression as part of the cell's effort to cope with nucleotide metabolism disruption. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Cisplatin forms DNA adducts, leading to DNA damage. This could potentially upregulate SPHAR as part of the cellular response to DNA repair mechanisms during S-phase. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Etoposide causes DNA strand breaks by inhibiting topoisomerase II, potentially affecting SPHAR expression as cells attempt to repair DNA damage and maintain genomic integrity. | ||||||
2′-Deoxy-2′,2′-difluorocytidine | 95058-81-4 | sc-275523 sc-275523A | 1 g 5 g | $56.00 $128.00 | ||
Gemcitabine is a nucleoside analog that inhibits DNA synthesis. It could hypothetically increase SPHAR expression as part of the cellular response to replication stress. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate inhibits dihydrofolate reductase, affecting nucleotide synthesis and potentially influencing SPHAR expression in response to impaired DNA replication. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid affects cell differentiation and proliferation. It could influence SPHAR expression hypothetically as part of its regulatory effects on cell cycle progression. | ||||||
Thymidine | 50-89-5 | sc-296542 sc-296542A sc-296542C sc-296542D sc-296542E sc-296542B | 1 g 5 g 100 g 250 g 1 kg 25 g | $49.00 $73.00 $270.00 $458.00 $1758.00 $114.00 | 16 | |
Thymidine, when used in high concentrations, can cause DNA synthesis imbalance and S-phase arrest, potentially affecting SPHAR expression as part of the thymidine block response. | ||||||
Bleomycin | 11056-06-7 | sc-507293 | 5 mg | $275.00 | 5 | |
Bleomycin induces DNA strand breaks, potentially upregulating SPHAR as part of the cellular response to genotoxic stress during DNA replication. | ||||||